Home › Funds › 1832 Asset Management L.P. › ELV
1832 Asset Management L.P. position in ELV
ELEVANCE HEALTH INC FORMERLY · Health Care
1832 Asset Management L.P. reported holding 972,022 shares of ELV (ELEVANCE HEALTH INC FORMERLY) in its Q3 2026 13F filing — a position valued at US$377.9M, representing 0.50% of its reported portfolio and ranking #45 among its reported holdings. 1832 Asset Management L.P. has disclosed ELV holdings in 13 of the last 13 reported quarters, going back to Q3 2023.
Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR
How 1832 Asset Management L.P.'s ELV position evolved
1832 Asset Management L.P. first disclosed a stake in ELV in Q3 2023 at 462,135 shares (US$201.2M). The position peaked in Q3 2026 at 972,022 shares, worth US$377.9M. Across 13 filings, 1832 Asset Management L.P. increased the stake 8 time(s), trimmed it 4 time(s) and left it unchanged 0 time(s). The most recent filing (Q3 2026) shows 972,022 shares valued at US$377.9M — an increase of 53,785 shares quarter over quarter.. Notable position changes include a 25% increase in Q4 2023 (shares rose 10% over the following quarter).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2023 | 462.13K | $201.22M | New |
| Q4 2023 | 579.75K | $273.39M | Add |
| Q1 2024 | 621.36K | $322.20M | Add |
| Q2 2024 | 615.74K | $333.64M | Reduce |
| Q3 2024 | 687.79K | $357.65M | Add |
| Q4 2024 | 821.58K | $303.08M | Add |
| Q1 2025 | 815.50K | $354.71M | Reduce |
| Q2 2025 | 784.84K | $305.27M | Reduce |
| Q3 2025 | 750.74K | $242.58M | Reduce |
| Q4 2025 | 762.20K | $267.19M | Add |
| Q1 2026 | 774.09K | $226.61M | Add |
| Q2 2026 | 918.24K | $355.11M | Add |
| Q3 2026 | 972.02K | $377.94M | Add |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About ELV and 13F data
ELV (ELEVANCE HEALTH INC FORMERLY) is a Health Care company. 23 other funds we track also report a position in ELV — the largest reported positions include Wellington Management Group (US$3.56B), WELLINGTON MANAGEMENT GROUP LLP (US$3.56B), Sanders Capital, LLC (US$2.27B). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding ELV
- Wellington Management Group 9.21M sh · $3.56B · Q2 2026
- WELLINGTON MANAGEMENT GROUP LLP 9.21M sh · $3.56B · Q2 2026
- Sanders Capital, LLC 5.83M sh · $2.27B · Q3 2026
- Harris Associates (Oakmark) 4.92M sh · $1.90B · Q2 2026
- HARRIS ASSOCIATES L P 4.92M sh · $1.90B · Q2 2026
- First Eagle Investment Management 4.20M sh · $1.63B · Q3 2026
- Artisan Partners Limited Partnership 3.76M sh · $1.46B · Q3 2026
More on 1832 Asset Management L.P.
FAQ
How long has 1832 Asset Management L.P. held ELV?
1832 Asset Management L.P. has disclosed ELV holdings in 13 of the last 13 reported quarters, going back to Q3 2023.
What is 1832 Asset Management L.P.'s current position in ELV?
As of Q3 2026, 1832 Asset Management L.P. holds 972.02K shares of ELV (ELEVANCE HEALTH INC FORMERLY), valued at $377.94M, representing 0.50% of its reported portfolio and ranking #45.
Has 1832 Asset Management L.P. been buying or selling ELV?
In the latest 13F filing (Q3 2026), 1832 Asset Management L.P. increased its position in ELV. The position peaked in Q3 2026 at 972.02K shares.
Which other funds hold ELV?
Other major institutional holders of ELV include Wellington Management Group, WELLINGTON MANAGEMENT GROUP LLP, Sanders Capital, LLC, among 23 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.